About this trial
This randomized clinical trial aims to compare the clinical and radiographic performance of four direct restorative materials used for restoring carious primary molars in children. Eligible children aged 4-8 years with posterior primary molars requiring direct restoration will be randomly allocated (1:1:1:1) to receive one of the following materials: an alkasite restorative material (Cention N), a self-cure bulk-fill resin composite (Stela; SDI), a conventional light-cured nanohybrid resin composite (Beautifil II), or a resin-modified glass ionomer cement (Riva Light Cure). Restorations will be evaluated using the Fédération Dentaire Internationale (FDI) World Dental Federation criteria. Postoperative sensitivity will be assessed at 48 hours using a 0-10 visual analogue scale (VAS). Clinical and radiographic follow-up assessments will be conducted at baseline and at scheduled recall visits
Eligibility criteria
Qualifiers
Age 4-8 years old.
Primary molars indicated for restorative treatment.
No pulp involvement or history of dental pain.
Cooperative children (Frankl: +ve or ++ve).
Disqualifiers
Pulp exposure after caries removal or clinical signs of irreversible pulpitis/necrosis.
Severe developmental enamel defects or insufficient enamel for bonding.
Trial design
Treatments tested in this trial
- Cention N
- Stela, SDI, Australia
- Beautifil II, Shofu, Japan
- Resin modified glass ionomer cement